Karyopharm Therapeutics (KPTI) Prepaid Assets (2012 - 2025)

Karyopharm Therapeutics has reported Prepaid Assets for 14 years, with the latest figure at $9.2 million in Q4 2025.

• For the quarter ending Q4 2025, Prepaid Assets fell 24.98% year-over-year to $9.2 million; the trailing twelve-month figure through Dec 2025 stood at $9.2 million (down 24.98% YoY), and the FY2025 full-year result was $9.2 million, down 24.98% from the prior year.
• Prepaid Assets for Q4 2025 stood at $9.2 million, up from $8.0 million in the prior quarter.
• The five-year high for Prepaid Assets was $31.5 million in Q3 2022, with the low at $8.0 million in Q3 2025.
• Historically, Prepaid Assets has averaged $14.0 million across 5 years, with a median of $12.8 million in 2021.
• Annual changes were most pronounced in 2022 — Prepaid Assets jumped 156.42% — and 2023, when it tumbled 57.63%.
• Karyopharm Therapeutics' Prepaid Assets stood at $14.0 million in 2021, then jumped by 41.19% to $19.8 million in 2022, then plunged by 40.4% to $11.8 million in 2023, then climbed by 3.66% to $12.2 million in 2024, then retreated by 24.98% to $9.2 million in 2025.
• The last three Prepaid Assets figures came in at $9.2 million (Q4 2025), $8.0 million (Q3 2025), and $8.2 million (Q2 2025), per Business Quant data.